Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
-
WALKER RIVER ANNOUNCES SIGNIFICANT GOLD INTERCEPTS AT THE LAPON CANYON GOLD PROJECT
-
Pipefy Leverages Oracle Cloud Infrastructure to Deliver its AI Agents to U.S. Customers
-
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
-
ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors
-
Par Pacific Announces Term Loan Repricing
-
VirTra Selects Nashville Police Department (GA) as 2025 Taskforce Santa Finalist
-
Society Pass Inc (Nasdaq: SOPA) Announces Evolution of its Business Model, Upcoming Investments in AI-Driven Data Centre and Telecoms Companies
-
Cerence AI Expands Beyond the Vehicle to New Areas of the Automotive Ecosystem with Launch of AI Agents
-
Stryker declares an $0.88 per share quarterly dividend
-
Vera Bradley Announces Third Quarter Fiscal Year 2026 Results
-
Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026
-
PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support
-
Premier Air Charter Strengthens Fleet with Challenger 604 Acquisition
-
Supplements 4 Muscle Announces Launch of New Informative Blog
-
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
-
QuestionPro Achieves ISO 42001 Certification, Strengthening Commitment to Ethical and Responsible AI Management
-
Consumers Drive 8% lift in Holiday Gift Card Purchases Over Thanksgiving Weekend
-
Nick Young Tractor Parts Wins “Best Family Business in Lincolnshire” at the Lincolnshire Marketing Awards
-
ImmuneWalk Therapeutics Announces Positive Results from Phase 1 SAD/MAD Study of IW-601, a First-In-Class Therapeutic with Broad Potential in Inflammatory and Autoimmune Diseases
-
Shirofune Wins Best Search Product/Platform in the 2025 Adweek Tech Stack Awards
-
BondBloxx Releases 2026 Fixed Income Outlook
-
Amaero Accelerates Growth Initiatives with Major Equipment Orders
-
Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment
-
EBANX drives the next phase of credit cards in LatAm with network tokenization for cross-border transactions
-
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY, MAAY, NUGY, SEMY, QBY, RGYY, HMYY and RT
-
Veriff Identity Fraud Report: Online Fraud Continues to Rise, Hitting E-Commerce and Financial Services Hardest
-
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
-
2026 RESO Board of Directors Announced
-
ZenaTech Signs Offer to Acquire a Surveying Firm in the US West Expanding Drone as a Service Footprint to Serve Precision Agriculture, Ranching and Wildfire Management
-
American Hotel Income Properties REIT LP Announces CEO Change
-
Streamex Corp. (NASDAQ: STEX) Acquires 9.9% Strategic Equity Stake in Royalty and Streaming Firm Empress Royalty Corp. Through a Premium Priced Share-for-Share Transaction at US$5.00 STEX with a Leadi
-
Mount Logan Capital Inc. Initiates Shareholder Record Search relating to expected $15 Million Tender Offer
-
Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization
-
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
-
Cemtrex Highlights Profitability Focus, Strategic Transformation, and Progress Toward Portfolio Expansion
-
Hope for PDCD Foundation Delivers Petition to FDA Urging Approval of the First Targeted PDCD Treatment
-
Stryker declares an $0.88 per share quarterly dividend
-
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
-
OTC Markets Group Welcomes Grayscale Bittensor Trust (TAO) to OTCQX
-
Oxford Lane Capital Corp. Provides November 2025 Net Asset Value Update
-
Grayscale® Bittensor Trust (GTAO) Begins Trading on OTC Markets and is Now SEC Reporting
-
Innventure Set to Join the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
-
Apolosign Unveils Three Family-Friendly Holiday Gifts as Americans Seek Practical, Heartwarming Tech This Season
-
zSpace Announces Strategic Restructuring to Strengthen Financial Foundation
-
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
-
VEON’s Banglalink Receives Regulatory Approval to Launch Digital Payment Services to Advance Financial Inclusion in Bangladesh
-
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
-
Kalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National Scale

